Grants and Contributions:
Title:
Development of novel and improved RNA cap and production capabilities
Agreement Number:
979247
Agreement Value:
$47,500.00
Agreement Date:
Sep 15, 2021 - Mar 18, 2022
Description:
This project involves the development of proprietary mRNA cap structures and mRNA production capacity using novel manufacturing methods in addition to the development and manufacturing of lipid nanoparticles (LNPs).
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6T 1Z3
Reference Number:
172-2021-2022-Q3-979247
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
714010279
Recipient Type:
For-profit organization
Recipient's Legal Name:
NanoVation Therapeutics Inc.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710